| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 03/22/2011 | US7910594 Antiproliferative agents; gene overexpression |
| 03/22/2011 | US7910585 Pyrimidine derivatives |
| 03/22/2011 | US7910583 [6,6] and [6,7]-bicyclic GPR119 G protein-coupled receptor agonists |
| 03/22/2011 | US7908735 Method and installation means for installing an electrical machine |
| 03/22/2011 | CA2500824C Tricyclic tetrahydroquinoline antibacterial agents |
| 03/22/2011 | CA2479363C Thiopyrimidine and isothiazolopyrimidine kinase inhibitors |
| 03/22/2011 | CA2460036C Medical devices containing rapamycin analogs |
| 03/22/2011 | CA2449215C (pyrido/thieno)-[f]-oxazepin-5-one derivatives as positive modulators of the ampa receptor |
| 03/17/2011 | WO2011031745A1 Antibacterial fluoroquinolone analogs |
| 03/17/2011 | WO2011031744A1 Antibacterial fluoroquinolone analogs |
| 03/17/2011 | WO2011031620A1 Solid compositions comprising an oxadiazoanthracene compound and methods of making and using the same |
| 03/17/2011 | US20110065914 Perfluoro macrocycles in 18f-labelling of macromolecules |
| 03/17/2011 | US20110065703 Novel agents of calcium ion channel modulators |
| 03/17/2011 | US20110065698 Novel protein kinase modulators |
| 03/17/2011 | US20110065697 2-oxy-benzoxazinone derivatives for the treatment of obesity |
| 03/17/2011 | US20110065696 Imidazoyl pyridine compounds and salts thereof |
| 03/17/2011 | US20110065687 Hydrazide compounds and uses thereof |
| 03/17/2011 | US20110065681 Amide compounds, compositions and uses thereof |
| 03/17/2011 | US20110065669 Oxazolobenzimidazole derivatives |
| 03/17/2011 | US20110064806 Solid compositions comprising an oxadiazoanthracene compound and methods of making and using the same |
| 03/16/2011 | EP2295442A2 Inhibitors of interleukin-1beta converting enzyme |
| 03/16/2011 | EP2295401A2 Deuterated hepatitis C protease inhibitors |
| 03/16/2011 | EP2294072A1 Triazine compounds as p13 kinase and mtor inhibitors |
| 03/16/2011 | EP2173756B1 Macrolactone derivatives |
| 03/16/2011 | CN101514208B Green synthesizing process for ofloxacin |
| 03/15/2011 | US7906649 Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes |
| 03/15/2011 | US7906528 Such as 5-(2,6-diethyl-phenyl)-1H-pyrrolo[2,3-C]pyridine, which binds C5a receptors with high affinity; for treatment of inflammatory, cardiovascular, and immune system disorders; kits |
| 03/15/2011 | US7906507 Oxadiazoanthracene compounds for the treatment of diabetes |
| 03/15/2011 | US7906506 Immunomodulators, inducing cytokine biosynthesis in animals; antiviral agents, antitumor agents; e.g. (11S)-1-Methyl-8-propyl-10,11-dihydro-8H-[1,4]oxazino[4',3':1,2]imidazo[4,5-c]quinolin-6-amine |
| 03/15/2011 | US7905928 Reactive dyes, processes for their preparation and their use |
| 03/15/2011 | CA2415611C Biologically active macrolides, compositions, and uses thereof |
| 03/10/2011 | US20110060140 Synthesis of (+) cortistatin a and related compounds |
| 03/10/2011 | US20110059946 Dual action antibiotics |
| 03/10/2011 | CA2773038A1 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| 03/09/2011 | EP2292625A1 Substituted spiro compounds and their use for producing pain-relief medicaments |
| 03/09/2011 | EP2292621A1 Vasopressin v1a antagonists |
| 03/09/2011 | EP2292620A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prohylaxis and treatment of disorders related thereto |
| 03/09/2011 | EP2292280A1 Medical devices containing rapamycin analogs |
| 03/09/2011 | EP2292222A1 Polymorphic Forms of a GABAA Agonist |
| 03/09/2011 | EP2291383A1 New classes of gabaa/bzr ligands |
| 03/08/2011 | US7902376 Process for preparing chiral dipeptidyl peptidase-IV inhibitor intermediates |
| 03/08/2011 | US7902366 NK1 antagonists |
| 03/08/2011 | US7902357 Process for the preparation of delmopinol and derivatives thereof |
| 03/08/2011 | US7902226 Dehalogeno-compounds |
| 03/08/2011 | US7902217 Indoles, 1H-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 03/08/2011 | US7902206 Polymorphic forms α, β and γ of rifaximin |
| 03/08/2011 | US7902196 Synthesis of avrainvillamide, strephacidin B, and analogues thereof |
| 03/08/2011 | US7902192 Inhibitors of P38 and methods of using the same |
| 03/08/2011 | US7902182 HIV integrase inhibitors |
| 03/08/2011 | CA2338504C Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| 03/03/2011 | WO2011025889A1 HEXAHYDROOXAZINOPTERINE COMPOUNDS FOR USE AS mTOR INHIBITORS |
| 03/03/2011 | WO2011024987A1 Aromatic fused heterocyclic derivative and pharmaceutical composition containing same |
| 03/03/2011 | WO2011024933A1 3-(biaryloxy) propionic acid derivative |
| 03/03/2011 | WO2011023733A1 Anhydrate forms of a pyridine derivative |
| 03/03/2011 | US20110053925 Hydroxamate-Based Inhibitors of Deacetylases |
| 03/03/2011 | US20110053923 Chemical compounds 610 |
| 03/03/2011 | US20110053921 Hexahydrooxazinopterine compounds |
| 03/03/2011 | US20110053910 2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes |
| 03/03/2011 | US20110053909 Compounds - 801 |
| 03/03/2011 | CA2772168A1 Anhydrate forms of a pyridine derivative |
| 03/02/2011 | EP2289890A1 Compounds for the treatment of multi-drug resistant bacterial infections |
| 03/02/2011 | EP2289483A1 Use of polymerisable macrocyclic polyethers and macrocyclic heteroanalogous polyethers in dental materials |
| 03/02/2011 | EP2288604A1 Annelated n-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
| 03/02/2011 | EP1581518B1 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 03/02/2011 | EP1064942B9 Sustained release preparation of a macrolide |
| 03/02/2011 | CN101305011B Pyridine derivatives and their use in the treatment of psychotic disorders |
| 03/02/2011 | CN101084225B Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic a ivity |
| 03/01/2011 | US7897632 Multi-cyclic cinnamide derivatives |
| 03/01/2011 | US7897608 39-desmethoxy-39-methyl derivatives of rapamycin |
| 03/01/2011 | US7897593 HIV integrase inhibitors |
| 02/24/2011 | WO2011021036A1 Polyketides analogues and methods for their production |
| 02/24/2011 | US20110046722 Oxazinyl isoflavonoid compounds, medicaments and use |
| 02/24/2011 | US20110046367 3-3-di-substituted-oxindoles as inhibitors of translation initiation |
| 02/23/2011 | EP2287167A1 Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 02/23/2011 | EP2287166A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 02/23/2011 | EP2287165A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 02/23/2011 | EP2287156A1 2,4-Di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 02/23/2011 | EP2286844A2 Antibody-drug conjugates and methods |
| 02/23/2011 | EP2285808A1 Spiro-indole derivatives for the treatment of parasitic diseases |
| 02/23/2011 | CN101981039A Substituted heteroarylamide oxazepinopyrimidone derivatives |
| 02/23/2011 | CN101981031A Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them |
| 02/23/2011 | CN101133064B Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists |
| 02/22/2011 | US7893160 Crosslinkable substituted fluorene compounds and conjugated oligomers or polymers based thereon |
| 02/22/2011 | US7893084 Viral polymerase inhibitors |
| 02/22/2011 | US7893074 inhibition of focal adhesion kinase or/and IGF-1 Receptor; for example: 2-[2-(2,5-Dimethoxy-phenylamino)-5-nitro-pyrimidin-4-ylamino]-N-methyl-benzenesulfonamide |
| 02/22/2011 | US7893056 Peptide deformylase inhibitors |
| 02/22/2011 | US7893055 HIV integrase inhibitors |
| 02/22/2011 | CA2470575C Spiroazacyclic compounds as monoamine receptor modulators |
| 02/22/2011 | CA2329181C 12,13-modified epothilone derivatives |
| 02/17/2011 | WO2011018510A1 New macrolides and their use |
| 02/17/2011 | US20110039883 Azolopyridin-2-one derivatives as lipase and phospholipase inhibitors |
| 02/17/2011 | US20110039840 Spirocyclic derivatives as histone deacetylase inhibitors |
| 02/17/2011 | US20110039838 Pyrrolotriazine compounds as kinase inhibitors |
| 02/17/2011 | US20110039836 Tricyclic antibiotics |
| 02/17/2011 | CA2769551A1 New macrolides and their use |
| 02/16/2011 | EP2284174A1 Intermediates for the preparation of benzoxazine derivatives and process for their preparation |
| 02/16/2011 | EP2283159A1 Synthesis of (+) cortistatin a and related compounds |
| 02/16/2011 | EP2283024A1 4-aryl-2-anilino-pyrimidines as plk kinase inhibitors |
| 02/16/2011 | EP2283017A1 Fused pyrimidineone compounds as trpv3 modulators |
| 02/16/2011 | CN101972669A Nucleoside preparation technology by using solvent-free melting method and catalyst used thereby |